Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michel Kranendonk, António Laires, José Rueff, Ronald W. Estabrook & Nico P. E. Vermeulen. (2000) Heterologous Expression of Xenobiotic Mammalian-Metabolizing Enzymes in Mutagenicity Tester Bacteria: An Update and Practical Considerations. Critical Reviews in Toxicology 30:3, pages 287-306.
Read now
Read now
Articles from other publishers (36)
Mark S. Johnson. 2003. Patty's Toxicology. Patty's Toxicology
1
107
.
Anam Shabbir, Kamran Haider, Kanwal Rehman, Muhammad Sajid Hamid Akash & Shuqing Chen. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
1
27
.
Chang-Hwei ChenChang-Hwei Chen. 2020. Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense. Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense
71
81
.
M.W. Duffel. 2018. Comprehensive Toxicology. Comprehensive Toxicology
407
428
.
J.Y. Cui & C.Y. Li. 2018. Comprehensive Toxicology. Comprehensive Toxicology
168
214
.
Sudheesh Sudhakaran, T. M. Archana & C. N. Aguilar. 2017. Bioresources and Bioprocess in Biotechnology. Bioresources and Bioprocess in Biotechnology
129
150
.
Yin-Tak Woo & David Y. Lai. 2001. Patty's Toxicology. Patty's Toxicology
1
96
.
Eula Bingham & William J. McGowan. 2001. Patty's Toxicology. Patty's Toxicology
1
92
.
Chang-Hwei ChenChang-Hwei Chen. 2012. Activation and Detoxification Enzymes. Activation and Detoxification Enzymes
37
48
.
W. Alhusainy, A. Paini, A. Punt, J. Louisse, A. Spenkelink, J. Vervoort, T. Delatour, G. Scholz, B. Schilter, T. Adams, P.J. van Bladeren & I.M.C.M. Rietjens. (2010) Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect. Toxicology and Applied Pharmacology 245:2, pages 179-190.
Crossref
Crossref
R.I. Sanchez & F.C. Kauffman. 2010. Comprehensive Toxicology. Comprehensive Toxicology
109
128
.
M.W. Duffel. 2010. Comprehensive Toxicology. Comprehensive Toxicology
367
384
.
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development
55
107
.
Katsuhiko Mizuno, Miki Katoh, Hirotoshi Okumura, Nao Nakagawa, Toru Negishi, Takanori Hashizume, Miki Nakajima & Tsuyoshi Yokoi. (2009) Metabolic Activation of Benzodiazepines by CYP3A4. Drug Metabolism and Disposition 37:2, pages 345-351.
Crossref
Crossref
Masato Ohbuchi, Masaaki Miyata, Daichi Nagai, Miki Shimada, Kouichi Yoshinari & Yasushi Yamazoe. (2009)
Role of Enzymatic
N
-Hydroxylation and Reduction in Flutamide Metabolite-Induced Liver Toxicity
. Drug Metabolism and Disposition 37:1, pages 97-105.
Crossref
Crossref
Kan Chen, Richard B. Cole, Vicente Santa Cruz, Ernest W. Blakeney, Mary F. Kanz & Tammy R. Dugas. (2008) Characterization of biliary conjugates of 4,4′-methylenedianiline in male versus female rats. Toxicology and Applied Pharmacology 232:2, pages 190-202.
Crossref
Crossref
Kan Chen, Tammy R. Dugas & Richard B. Cole. (2008) Liquid chromatography–electrospray tandem mass spectrometry investigations of fragmentation pathways of biliary 4,4′-methylenedianiline conjugates produced in rats. Analytical and Bioanalytical Chemistry 391:1, pages 271-278.
Crossref
Crossref
Peter Gresner, Jolanta Gromadzinska & Wojciech Wasowicz. (2007) Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57:1, pages 1-25.
Crossref
Crossref
Rika Goda, Daichi Nagai, Yuji Akiyama, Kiyohiro Nishikawa, Isao Ikemoto, Yoshio Aizawa, Kiyoshi Nagata & Yasushi Yamazoe. (2006)
DETECTION OF A NEW
N
-OXIDIZED METABOLITE OF FLUTAMIDE,
N
-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]HYDROXYLAMINE, IN HUMAN LIVER MICROSOMES AND URINE OF PROSTATE CANCER PATIENTS
. Drug Metabolism and Disposition 34:5, pages 828-835.
Crossref
Crossref
Li-Quan Wang, Hans-Joachim Lehmler, Larry W. Robertson & Margaret O. James. (2006) Polychlorobiphenylols are selective inhibitors of human phenol sulfotransferase 1A1 with 4-nitrophenol as a substrate. Chemico-Biological Interactions 159:3, pages 235-246.
Crossref
Crossref
Yin-Tak Woo & David Y. Lai. 2001. Patty's Toxicology. Patty's Toxicology.
Vyas Sharma & Michael W. Duffel. (2002) Comparative Molecular Field Analysis of Substrates for an Aryl Sulfotransferase Based on Catalytic Mechanism and Protein Homology Modeling. Journal of Medicinal Chemistry 45:25, pages 5514-5522.
Crossref
Crossref
John H Weisburger. (2002) Comments on the history and importance of aromatic and heterocyclic amines in public health. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 506-507, pages 9-20.
Crossref
Crossref
Elizabeth K. Weisburger & Vera W. Hudson. 2001. Patty's Toxicology. Patty's Toxicology.
Mary D. Boudreau, David G. BakerH. Wayne Taylor, Steven A. Barker & Jay C. Means. (2016) Suppression of Arylamine Toxicity in the Fischer-344 Rat Following Ingestion of a Complex Mixture. Toxicologic Pathology 29:3, pages 333-343.
Crossref
Crossref
Kouichi Yoshinari, Evgeniy V. Petrotchenko, Lars C. Pedersen & Masahiko Negishi. (2001) Crystal structure‐based studies of cytosolic sulfotransferase. Journal of Biochemical and Molecular Toxicology 15:2, pages 67-75.
Crossref
Crossref
Herbert C Lee, Piyush Kumar, Alexander J McEwan, Leonard I Wiebe & John R Mercer. (2000) Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside. Nuclear Medicine and Biology 27:1, pages 61-68.
Crossref
Crossref
F-I Hsieh, Y-S Pu, H-D Chern, L-I Hsu, H-Y Chiou & C-J Chen. (1999) Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. British Journal of Cancer 81:3, pages 537-541.
Crossref
Crossref
IOANNIS F. FILIADIS, IOANNIS GEORGIOU, YANNIS ALAMANOS, VASILIS KRANAS, XENOPHON GIANNAKOPOULOS & DIMITRIOS LOLIS. (1999) GENOTYPES OF N-ACETYLTRANSFERASE-2 AND RISK OF BLADDER CANCER: A CASE-CONTROL STUDY. The Journal of Urology 161:5, pages 1672-1675.
Crossref
Crossref
Yukiaki Kuroda & Yukihiko Hara. (1999) Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutation Research/Reviews in Mutation Research 436:1, pages 69-97.
Crossref
Crossref
Zenon Apostolides, Douglas A Balentine, Matthew E Harbowy, Yukihiko Hara & John H Weisburger. (1997) Inhibition of PhIP mutagenicity by catechins, and by theaflavins and gallate esters. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 389:2-3, pages 167-172.
Crossref
Crossref
P J O'Brien, B F Hales, P D Josephy, A Castonguay, Y Yamazoe & F P Guengirich. (1996) Chemical carcinogenesis, mutagenesis, and teratogenesis. Canadian Journal of Physiology and Pharmacology 74:5, pages 565-571.
Crossref
Crossref
Charles C. Kiehlbauch, Yim F. Lam & David P. Ringer. (1995) Homodimeric and Heterodimeric Aryl Sulfotransferases Catalyze the Sulfuric Acid Esterification of N-Hydroxy-2-acetylaminofluorene. Journal of Biological Chemistry 270:32, pages 18941-18947.
Crossref
Crossref
Thomas Walle, E.Alison Eaton & U.Kristina Walle. (1995) Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochemical Pharmacology 50:5, pages 731-734.
Crossref
Crossref
Peter I. Mackenzie, M. W. Anders, Yasushi Yamazoe, Richard M. Weinshilboum, Kathleen M. Knights & John Caldwell. 1995. Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s. Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s
161
168
.
B. Clement & S. Linne. (1994) P216 genotoxic activities of N-hydroxylated derivatives of amidines, guanidines and amidinohydrazones in salmonella typhimurium. European Journal of Pharmaceutical Sciences 2:1-2, pages 172.
Crossref
Crossref